Turbine
Hungary
- Budapest
- 20/06/2023
- Series A
- $6,004,625
Turbine was founded for a simple reason; to understand complex cancers better than existing experimental tools in order to solve unmet oncology needs.
Through a multidisciplinary team that unites computer science and molecular biology, and the world's most intricate simulation of cell behavior, we identify treatment options for the 70% of cancers that are currently unexplored.
We use our platform, the Simulated Cell™, to uncover novel biological insights across both new and known targets. This allows us to provide a fresh biological context, define responsive patient populations, and design drug combination approaches that diminish resistance.
With a process proven by clinical stage predictions and a proprietary pipeline, we continue our mission of unlocking cancer complexity to deliver next-generation precision therapeutics.
- Industry Biotechnology Research
- Website https://turbine.ai/
- LinkedIn https://www.linkedin.com/company/turbine-inc/
Scale Social AI | $1,300,000 | (Nov 19, 2025)
Orion | $17,500,000 | (Nov 19, 2025)
Asseta AI | $4,200,000 | (Nov 19, 2025)
Hammerhead | $10,000,000 | (Nov 19, 2025)
Condukt | $10,000,000 | (Nov 19, 2025)
Nudge Security | $22,500,000 | (Nov 19, 2025)
GetVocal AI | $26,000,000 | (Nov 19, 2025)
Cellbyte | $2,750,000 | (Nov 19, 2025)
Xenia | $12,000,000 | (Nov 19, 2025)
Venn | $52,000,000 | (Nov 19, 2025)
Planet Smart | $1,000,000 | (Nov 19, 2025)
Barker | $3,500,000 | (Nov 19, 2025)